Discovery, trials, manufacturing, and commercial — we operate across the molecule's whole life and connect the seams that usually drop the value.
The handful of moves that decide whether a r&d · commercial program compounds — and the ones we deliberately deprioritize.
AI-augmented target discovery and lead optimisation, with the lab and the algorithm on the same team.
Predictive site selection, decentralised trial design, and the data spine that holds it together.
Brand, medical, and access on the same plan — with the field force enabled by software, not slides.
The practices that lead in r&d · commercial engagements — staffed senior, run as one program.
Re-engineered site selection and study start-up to compress the path to first patient — without trading off quality.
“They were equally comfortable in the lab notebook and the launch plan.”